ManagingComplexHIVPatients
Meeting category
Date(s)
24 Nov 2020
EACCME Credits
2
Educational Partner
Managing Complex HIV Patients – European Edition is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Sponsor logos
ViiW

Managing Complex HIV Patients 2020 - European Edition

Related Enduring Materials

Enduring Materials
- 15:00
15:00 CET
Opening of the Webinar; Welcome and Goals by Chair ​
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
15:05 CET
How to identify the complex HIV patient & approach to treatment
Daniel Kuritzkes, MD
Brigham and Women's Hospital / Harvard Medical School, United States
15:20 CET
Drug options for the complex HIV patient, what are they and how best to use them
Chloe Orkin, MBChB, FRCP, MD
Queen Mary University of London, United Kingdom
15:40 CET
Understanding and managing multi-class resistance
Anton Pozniak, MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
15:55 CET
Clinical case: Focus on drug resistance
Miłosz Parczewski, MD, PhD
Pomeranian Medical University, Szczecin, Poland
16:10 CET
Discussion and Q/A with all speakers: How to design an optimal regimen for the complex patient
16:35 CET
Pharmacological considerations in the complex HIV patient ​
Marta Boffito, MD, PhD, FRCP, MBA
Chelsea and Westminster Hospital NHS Foundation Trust; Imperial College London; United Kingdom
16:55 CET
Managing toxicity in the complex HIV patient ​
Laura Waters, MD, FRCP
Central & North West London NHS Foundation Trust, United Kingdom
17:15 CET
Clinical case: Focus on co-morbidities and toxicity
Josep Llibre, MD, PhD
Fundació Lluita contra la Sida; Hospital Universitari Germans Trias i Pujol, Spain
17:30 CET
Discussion and Q/A with all speakers: How to manage Toxicity and Drug Interactions in the complex patient
17:50 CET
Closure of the Webinar
Laura Waters, MD, FRCP
Central & North West London NHS Foundation Trust, United Kingdom
Overview

This program was specially tailored towards the management of complex HIV patients in Europe. The program focusing on the management of these patients in the United States took place on 15 September 2020. For information, click here.

Welcome

Despite improved antiretroviral regimens, virological failure and the emergence of drug resistance remains an ongoing challenge throughout Europe. This includes both patients recently infected as well as veterans of older regimens. Although the resources, diagnostics, and soon drugs, required for the improved care of complex patients are now available in many parts of Europe, there remains a knowledge gap in how to best use them. Acquiring and interpreting resistance data correctly, incorporating co-morbidities and co-medications data, and then deciding on the optimal next regimen for patients with limited treatment options requires a high level of expertise. Managing these complex HIV patients require a greater knowledge and understanding in terms of adherence, resistance, aging, comorbidities, and polypharmacy.

​This webinar was designed for European HIV physicians who would like to improve their knowledge of identifying and managing patients with limited treatment options, as well as new antiretroviral drugs for optimizing the treatment of these patients.

This interactive 3-hour webinar took place on 24 November 2020 at 15:00 CET and provided the most up-to-date information from international experts.

Program Director
General Information 
Learning Objectives
At the completion of the activity participants will have:

- Improved knowledge of the definition on complex patients and the challenges of their care;

- Acquired tools and understanding on how best to Identify the complex HIV patient in their clinical practice;

- Greater understanding of the new treatment options available for these patients, including recently presented clinical trials;

- Learned how best to integrate these new drugs into optimal combination regimens for complex patients, considering their local country setting; and

- Improved their skills in managing drug-drug interactions and toxicities in these complex patients.
Practical Information 
Certificate of Attendance
A certificate of attendance was sent to participants that successfully completed the meeting and post-meeting survey.
Language
The official language of the meeting was English.

Disclaimer
This meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the meeting or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the meeting.
Liability and Insurance
By registering for the meeting, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the meeting is finished, provided that the speaker has given permission to do so.
Accreditation
UEMS_logo_Small

The Managing Complex HIV Patients Webinar - European Edition, Utrecht (livestream), Netherlands, 24/11/2020 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 2 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities   

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Support

Managing Complex HIV Patients – US Edition is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.